A systematic review and meta-analysis of single-incision mini-slings (MiniArc) versus transobturator mid-urethral slings in surgical management of female stress urinary incontinence. Issue 14 (April 2018)

• Record Type: Journal Article
• Authors: Jiao, Binbin; Lai, Shicong; Xu, Xin; Zhang, Meng; Diao, Tongxiang; Zhang, Guan
• Other Names: Mancini. Vito section editor.
• Is Part Of: Medicine. Volume 97:Issue 14(2018)
• Publication Date: 2018-04
• Subjects: MiniArc -- single-incision mini-sling -- stress urinary incontinence -- TOT -- transobturator midurethral slings -- TVT-O; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000010283
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract: Background: To assess the current evidence of effectiveness and safety of single-incision mini-slings (MiniArc) versus transobturator midurethral slings in the management of female stress urinary incontinence (SUI). Methods: A systematic search was performed from the electronic databases including PubMed, EMBASE, and Cochrane Library by November 2017. Using RevMan5.3 statistical software, the primary outcomes including subject and objective cure rates at 6 to 24 months follow-up were evaluated. Meanwhile, analysis was also performed for comparing the secondary outcomes such as peri- and postoperative complications, operative data, and quality of life. Results: Six randomized controlled trials (RCTs) and 6 retrospective cohort studies involving 1794 patients with SUI were analyzed based on the inclusion criteria. On the basis of our analysis, MiniArc was proven to have a noninferior clinical efficacy compared with transobturator midurethral slings with respect to the objective cure rate (risk ratio [RR] = 0.98, 95% confidence interval [CI] 0.94–1.03, P = .43) and subjective cure rate (RR = 0.97, 95% CI 0.91–1. 04, P = .38). In addition, pooled analysis showed that MiniArc had significantly lower postoperative pain scores (mean difference [MD] = −1.70, 95% CI −3.17 to −0.23, P = .02) and less postoperative groin pain (RR = 0.42, 95% CI 0.18–0.98, P = .04). Moreover, the MiniArc group also had a significantly shorter operation time (MD = −6.12, 95% CI −8.61 to −3.64, P < .001), less blood loss (MD = −16.67, 95% CI −26.29 to −7.05, P < .001), shorter in-patient stay (MD = 1.30, 95% CI −1.74 to −0.86, P < .001), and less urinary retention risk (RR = 1.15, 95% CI 0.46–2.87, P = .77). However, overall evidence was insufficient to suggest a statistically significant difference in the adverse event profile for MiniArc compared with transobturator slings. Conclusions: This meta-analysis indicates that MiniArc is an effective method treating SUI. When compared with transobturator slings, it not only has a similar high cure rates, but also is associated with shorter operation time, less blood loss, more favorable recovery time, lower postoperative pain scores, less postoperative groin pain, less urinary retention, and absence of a visible wound. However, the findings of this study should be further confirmed by well-designed prospective RCTs with a larger patient series.